Drug persistence of omalizumab, cyclosporine, and hydroxychloroquine in antihistamine-refractory chronic spontaneous urticaria: A biomarker-stratified real-world study.
- DOI
- 10.12932/ap-260126-2221
- Published
- 2026 Jul 29
- Container
- Asian Pacific journal of allergy and immunology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.12932/ap-260126-2221,
title = {Drug persistence of omalizumab, cyclosporine, and hydroxychloroquine in antihistamine-refractory chronic spontaneous urticaria: A biomarker-stratified real-world study.},
author = {Sheu HS and Sheu HS and Sheu JP and Juan CK and Sheu HS and Sheu HS and Sheu HS},
year = {2026},
journal = {Asian Pacific journal of allergy and immunology},
doi = {10.12932/ap-260126-2221},
url = {https://doi.org/10.12932/ap-260126-2221}
}RIS
TY - JOUR TI - Drug persistence of omalizumab, cyclosporine, and hydroxychloroquine in antihistamine-refractory chronic spontaneous urticaria: A biomarker-stratified real-world study. AU - Sheu HS AU - Sheu HS AU - Sheu JP AU - Juan CK AU - Sheu HS AU - Sheu HS AU - Sheu HS PY - 2026 JO - Asian Pacific journal of allergy and immunology DO - 10.12932/ap-260126-2221 UR - https://doi.org/10.12932/ap-260126-2221 ER -
APA
HS, S., HS, S., JP, S., CK, J., HS, S., HS, S., & HS, S. (2026). Drug persistence of omalizumab, cyclosporine, and hydroxychloroquine in antihistamine-refractory chronic spontaneous urticaria: A biomarker-stratified real-world study.. Asian Pacific journal of allergy and immunology. https://doi.org/10.12932/ap-260126-2221
Source records
- pubmed · retrieved 2026-09-26T03:22:05.969Z